Keyphrases
13-HODE
18%
5-hydroxyeicosatetraenoic Acid
9%
5-lipoxygenase (5-LOX)
9%
Amyotrophic Lateral Sclerosis
100%
As(V)
9%
Biological Activity
9%
Cell Systems
9%
Clinical Parameters
9%
Concentration Level
9%
Disease Duration
9%
Disease Onset
9%
Docosahexaenoic Acid
9%
Further Analysis
9%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
100%
Human Plasma
9%
Hydroxylated Metabolites
9%
Inflammation
36%
Isoprostanes
9%
Linoleic Acid
9%
Lipid Derivatives
9%
Lipidomics
9%
Maresins
9%
Novel Lipids
9%
Octadecadienoic Acid
18%
Oxylipin Profiles
18%
Oxylipins
100%
Plasma Oxylipins
9%
Plasma Samples
18%
Plasmatic Level
9%
Pro-resolving Mediators
9%
Targeted Analysis
9%
Biochemistry, Genetics and Molecular Biology
Anabolism
14%
Arachidonate 5-Lipoxygenase
14%
Biological Activity
14%
Blood Plasma
100%
Docosahexaenoic Acid
14%
Eicosatetraenoic Acid
14%
High-Performance Liquid Chromatography
100%
Isoprostane
14%
Linoleic Acid
14%
Lipid
14%
Lipidomics
14%
Maresin
14%
Mediator
14%
Metabolite
57%
Oxylipin
100%
Tandem Mass Spectrometry
100%
Neuroscience
5 Hydroxyicosatetraenoic Acid
9%
Amyotrophic Lateral Sclerosis
100%
Anabolism
9%
Arachidonate 5-Lipoxygenase
9%
Blood Plasma
100%
Docosahexaenoic Acid
9%
Isoprostane
9%
Linoleic Acid
9%
Liquid Chromatography-Mass Spectrometry
100%
Maresin
9%
Oxylipin
100%
Pharmacology, Toxicology and Pharmaceutical Science
5 Hydroxyicosatetraenoic Acid
9%
Amyotrophic Lateral Sclerosis
100%
Arachidonate 5 Lipoxygenase
9%
Biological Activity
9%
Disease
9%
Disease Duration
9%
Docosahexaenoic Acid
9%
High Performance Liquid Chromatography
100%
Inflammation
36%
Isoprostane Derivative
9%
Linoleic Acid
9%
Oxylipin
100%
Immunology and Microbiology
Biological Activity
14%
Blood Plasma
100%
High Performance Liquid Chromatography
100%
Isoprostane Derivative
14%
Mediator
14%
Metabolite
57%
Tandem Mass Spectrometry
100%